or Try an Advanced Search...

    Technical Analysis for NYXH - Nyxoah SA

    Grade Last Price % Change Price Change
    F 8.28 0.85% 0.07
    NYXH closed up 0.85 percent on Thursday, November 21, 2024, on 17 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical NYXH trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 0.85%
    Narrow Range Bar Range Contraction 0.85%
    Lower Bollinger Band Walk Weakness 0.85%
    Inside Day Range Contraction 0.85%
    Oversold Stochastic Weakness 0.85%
    Lower Bollinger Band Walk Weakness 1.85%
    Down 3 Days in a Row Weakness 1.85%
    Older End-of-Day Signals for NYXH ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 7 hours ago
    Outside Day about 7 hours ago
    Fell Below Previous Day's Low about 7 hours ago
    Down 1% about 7 hours ago
    Up 2% about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    NYXH Chart by TradingView
    Basic chart:

    Profile

    Nyxoah is a pioneering medical device company developing a breakthrough therapeutic solution for the treatment of Obstructive Sleep Apnea (OSA). Nyxoah’s team is driven by the vision that OSA sufferers should benefit from the latest and greatest innovations, for better health outcomes, higher patient comfort and quality of life. At the heart of Nyxoah’s innovation is a unique neurostimulation technology with more than 160 patents submitted worldwide.
    Classification
    Sector: Healthcare
    Industry: Medical Instruments & Supplies
    Keywords: Medicine Clinical Medicine Sleep Apnea Sleep Disorders Obstructive Sleep Apnea Neurostimulation Technology Osa

    Is NYXH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024
    Nov 8 Nyxoah S.A. (NYXH) Q3 2024 Earnings Call Transcript
    Nov 7 Nyxoah GAAP EPS of -€0.49, revenue of €1.26M
    Nov 7 Nyxoah SA (NYXH) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
    Nov 7 Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates
    Nov 6 Nyxoah Reports Third Quarter Financial and Operating Results
    Nov 4 Nyxoah appoints John Landry as CFO
    Nov 4 Nyxoah Appoints John Landry as Chief Financial Officer
    Oct 9 Nyxoah SA (NYXH) Q2 2024 Earnings Call Highlights: Strategic Growth and US Market Preparations
    Oct 9 Information on the total number of voting rights and shares
    See more NYXH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.0
    52 Week Low 4.0016
    Average Volume 81,905
    200-Day Moving Average 9.99
    50-Day Moving Average 9.11
    20-Day Moving Average 9.10
    10-Day Moving Average 8.55
    Average True Range 0.44
    RSI (14) 33.77
    ADX 32.74
    +DI 10.67
    -DI 25.15
    Chandelier Exit (Long, 3 ATRs) 8.70
    Chandelier Exit (Short, 3 ATRs) 9.33
    Upper Bollinger Bands 10.39
    Lower Bollinger Band 7.81
    Percent B (%b) 0.18
    BandWidth 28.40
    MACD Line -0.30
    MACD Signal Line -0.15
    MACD Histogram -0.1484
    Fundamentals Value
    Market Cap 237.42 Million
    Num Shares 28.7 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -4.57
    Price-to-Sales 94.38
    Price-to-Book 2.89
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.84
    Resistance 3 (R3) 8.83 8.63 8.75
    Resistance 2 (R2) 8.63 8.49 8.64 8.72
    Resistance 1 (R1) 8.46 8.40 8.36 8.47 8.69
    Pivot Point 8.26 8.26 8.21 8.26 8.26
    Support 1 (S1) 8.08 8.12 7.98 8.09 7.87
    Support 2 (S2) 7.88 8.03 7.89 7.84
    Support 3 (S3) 7.71 7.88 7.81
    Support 4 (S4) 7.72